{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T18:02:44Z","timestamp":1771956164022,"version":"3.50.1"},"reference-count":91,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.humimm.2015.09.038","type":"journal-article","created":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T19:28:53Z","timestamp":1443727733000},"page":"781-788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Role of stem cells in spondyloarthritis: Pathogenesis, treatment and complications"],"prefix":"10.1016","volume":"76","author":[{"given":"Rebecca S.Y.","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.humimm.2015.09.038_b0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5312\/wjo.v2.i12.07","article-title":"Classification criteria for spondyloarthropathies","volume":"2","author":"Akgul","year":"2011","journal-title":"World J. Orthop."},{"issue":"6","key":"10.1016\/j.humimm.2015.09.038_b0010","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2217\/ijr.12.61","article-title":"The new ASAS classification criteria for axial and peripheral spondyloarthritis","volume":"7","author":"Lipton","year":"2012","journal-title":"Int. J. Clin. Rheumatol."},{"key":"10.1016\/j.humimm.2015.09.038_b0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11926-013-0317-3","article-title":"Classification criteria: peripheral spondyloarthropathy and psoriatic arthritis","volume":"15","author":"Taylor","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"issue":"9","key":"10.1016\/j.humimm.2015.09.038_b0020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11926-013-0351-1","article-title":"Epidemiology of spondyloarthritis: a review","volume":"15","author":"Bakland","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"issue":"6","key":"10.1016\/j.humimm.2015.09.038_b0025","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/acr.21621","article-title":"Prevalence of axial spondylarthritis in the United States: estimates from a cross-sectional survey","volume":"64","author":"Reveille","year":"2012","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"4","key":"10.1016\/j.humimm.2015.09.038_b0030","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","article-title":"Global prevalence of ankylosing spondylitis","volume":"53","author":"Dean","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.humimm.2015.09.038_b0035","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.autrev.2011.01.011","article-title":"What is the role of HLA-B27 in spondyloarthropathies?","volume":"10","author":"Chatzikyriakidou","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.humimm.2015.09.038_b0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molimm.2013.07.013","article-title":"HLA-B27 misfolding and ankylosing spondylitis","volume":"57","author":"Colbert","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.humimm.2015.09.038_b0045","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/ard.2003.011023","article-title":"Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: a brief report and literature review","volume":"62","author":"Keller","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.humimm.2015.09.038_b0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jbspin.2011.09.018","article-title":"Biomarkers in spondyloarthritis: from pathophysiology to disease assessment","volume":"79","author":"Maksymowych","year":"2012","journal-title":"Joint Bone Spine"},{"issue":"1","key":"10.1016\/j.humimm.2015.09.038_b0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molimm.2013.07.016","article-title":"Inflammatory pathways in spondyloarthritis","volume":"57","author":"Hreggvidsdottir","year":"2014","journal-title":"Mol. Immunol."},{"issue":"12","key":"10.1016\/j.humimm.2015.09.038_b0060","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1002\/art.27251","article-title":"Mediators of Structural Remodeling in Peripheral Spondylarthritis","volume":"60","author":"Vandooren","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.humimm.2015.09.038_b0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/ar592","article-title":"Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-\u03b1 therapy and other novel approaches","volume":"4","author":"Braun","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.humimm.2015.09.038_b0070","first-page":"e102","article-title":"Seronegative spondyloarthropathies: evolving concepts regarding diagnosis and treatment","volume":"1","author":"Papagoras","year":"2012","journal-title":"J. Spine"},{"key":"10.1016\/j.humimm.2015.09.038_b0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4172\/2161-1149.1000119","article-title":"Overview of drug therapy for spondyloarthritis","volume":"3","author":"Keith","year":"2013","journal-title":"Rheumatol. Curr. Res."},{"issue":"1","key":"10.1016\/j.humimm.2015.09.038_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2005.02806.x","article-title":"Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I\/II studies, prospective randomized trials and future directions","volume":"141","author":"Tyndall","year":"2005","journal-title":"Clin. Exp. Immunol."},{"issue":"9","key":"10.1016\/j.humimm.2015.09.038_b0085","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.4155\/cli.11.102","article-title":"Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives","volume":"1","author":"Gu\u00e9rit","year":"2011","journal-title":"Clin. Invest."},{"key":"10.1016\/j.humimm.2015.09.038_b0090","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/asheducation-2011.1.280","article-title":"Successes and failures of stem cell transplantation in autoimmune diseases","volume":"2011","author":"Tyndall","year":"2011","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"issue":"7","key":"10.1016\/j.humimm.2015.09.038_b0095","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.autrev.2012.10.004","article-title":"Stem cells in autoimmune diseases: implications for pathogenesis and future trends in therapy","volume":"12","author":"Cipriani","year":"2013","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.humimm.2015.09.038_b0100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1517\/14728222.2013.746954","article-title":"Anti-inflammatory role and immunomodulation of mesenchymal stem cells in systemic joint diseases: potential for treatment","volume":"17","author":"MacFarlane","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"issue":"4","key":"10.1016\/j.humimm.2015.09.038_b0105","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.berh.2010.01.008","article-title":"Stem cells in the treatment of inflammatory arthritis","volume":"24","author":"Tyndall","year":"2010","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.humimm.2015.09.038_b0110","doi-asserted-by":"crossref","DOI":"10.1093\/qjmed\/hcu033","article-title":"Mesenchymal stem cells, autoimmunity and rheumatoid arthritis","author":"El-Jawhari","year":"2014","journal-title":"QJM"},{"issue":"6","key":"10.1016\/j.humimm.2015.09.038_b0115","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/MAJ.0b013e318294457f","article-title":"The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States","volume":"345","author":"Reveille","year":"2013","journal-title":"Am. J. Med. Sci."},{"issue":"10","key":"10.1016\/j.humimm.2015.09.038_b0120","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/ard.2004.029207","article-title":"Prevalence of spondyloarthropathies in France: 2001","volume":"64","author":"Saraux","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.humimm.2015.09.038_b0125","first-page":"117","article-title":"Rheumatoid arthritis and spondyloarthropathies: geographical variations in prevalence in France","volume":"34","author":"Roux","year":"2007","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.humimm.2015.09.038_b0130","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/ard.2010.141598","article-title":"Prevalence of spondyloarthritis and its subtypes in southern Sweden","volume":"70","author":"Haglund","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.humimm.2015.09.038_b0135","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MAJ.0b013e31820f8c99","article-title":"Epidemiology of spondyloarthritis in North America","volume":"341","author":"Reveille","year":"2011","journal-title":"Am. J. Med. Sci."},{"issue":"3","key":"10.1016\/j.humimm.2015.09.038_b0140","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.berh.2006.02.001","article-title":"Concepts and epidemiology of spondyloarthritis","volume":"20","author":"Sieper","year":"2006","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.humimm.2015.09.038_b0145","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","article-title":"Ankylosing spondylitis","volume":"369","author":"Braun","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2015.09.038_b0150","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(73)91360-3","article-title":"Ankylosing spondylitis and HL-A27","volume":"1","author":"Brewerton","year":"1973","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.humimm.2015.09.038_b0155","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/art.1780270301","article-title":"The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.humimm.2015.09.038_b0160","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/ard.55.4.268","article-title":"HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom","volume":"55","author":"Brown","year":"1996","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.humimm.2015.09.038_b0165","first-page":"996","article-title":"Reiters disease and HL-A27","volume":"2","author":"Brewerton","year":"1974","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.humimm.2015.09.038_b0170","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/rheumatology\/33.10.927","article-title":"Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity","volume":"33","author":"Gratac\u00f3s","year":"1994","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.humimm.2015.09.038_b0175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/ard.60.1.36","article-title":"Low T cell production of TNFa and IFNc in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism","volume":"60","author":"Rudwaleit","year":"2001","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.humimm.2015.09.038_b0180","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/annrheumdis-2011-200439","article-title":"Association between the IL-1 family gene cluster and spondyloarthritis","volume":"71","author":"Monnet","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.humimm.2015.09.038_b0185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3899\/jrheum.120246","article-title":"Synovial biomarkers in psoriatic arthritis","volume":"89","author":"Fiocco","year":"2012","journal-title":"J. Rheumatol. Suppl."},{"key":"10.1016\/j.humimm.2015.09.038_b0190","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1002\/art.23998","article-title":"Identification of interleukin-7 as a candidate disease mediator in spondylarthritis","volume":"58","author":"Rihl","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.humimm.2015.09.038_b0195","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00296-009-0883-x","article-title":"Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis","volume":"29","author":"Wang","year":"2009","journal-title":"Rheumatol. Int."},{"issue":"7","key":"10.1016\/j.humimm.2015.09.038_b0200","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+CD4-CD8- entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.humimm.2015.09.038_b0205","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/ard.2005.041137","article-title":"\u2018ASsessment in AS\u2019 international working group; European League Against Rheumatism. ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"65","author":"Zochling","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.humimm.2015.09.038_b0210","first-page":"780","article-title":"Ankylosing spondylitis: an update","volume":"42","author":"Golder","year":"2013","journal-title":"Aust. Fam. Physician"},{"issue":"4","key":"10.1016\/j.humimm.2015.09.038_b0215","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.humimm.2015.09.038_b0220","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar3257","article-title":"Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells inducedCCR4+CCR6+ Th\/Treg cell subset imbalance in ankylosing spondylitis","volume":"13","author":"Wu","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"19","key":"10.1016\/j.humimm.2015.09.038_b0225","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1073\/pnas.83.19.7182","article-title":"Isolation and characterization of a cDNA encoding a human liver\/bone\/kidney-type alkaline phosphatase","volume":"83","author":"Weiss","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"14","key":"10.1016\/j.humimm.2015.09.038_b0230","doi-asserted-by":"crossref","first-page":"9445","DOI":"10.1073\/pnas.142063399","article-title":"Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization","volume":"99","author":"Hessle","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"15\u201316","key":"10.1016\/j.humimm.2015.09.038_b0235","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.lfs.2009.01.013","article-title":"TNF\u03b1 and IL1\u03b2 inhibit RUNX2 and collagen expression but increase alkalinephosphatase activity and mineralization in human mesenchymal stem cells","volume":"84","author":"Ding","year":"2009","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.humimm.2015.09.038_b0240","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbrc.2012.12.036","article-title":"Autocrine stimulation of osteoblast activity by Wnt5a in response to TNF-\u03b1 in human mesenchymal stem cells","volume":"430","author":"Briolay","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.humimm.2015.09.038_b0245","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/stem.1040","article-title":"Induction of osteogenesis in mesenchymal stem cells by activated monocytes\/macrophages depends on oncostatin M signaling","volume":"30","author":"Guihard","year":"2012","journal-title":"Stem cells"},{"key":"10.1016\/j.humimm.2015.09.038_b0250","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0002-9440(10)61120-0","article-title":"Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand","volume":"160","author":"de Hooge","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.humimm.2015.09.038_b0255","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/art.10972","article-title":"Growth plate damage, a feature of juvenile idiopathic arthritis, can be induced by adenoviral gene transfer of oncostatin M: a comparative study in gene-deficient mice","volume":"48","author":"de Hooge","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.humimm.2015.09.038_b0260","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.bbrc.2011.12.106","article-title":"Mesenchymal stem cell isolation and characterization from human spinal ligaments","volume":"362","author":"Asari","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.humimm.2015.09.038_b0265","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.bbrc.2013.06.019","article-title":"Immunohistochemical localization of mesenchymal stem cells in ossified human spinal ligaments","volume":"436","author":"Chin","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.humimm.2015.09.038_b0270","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jbspin.2013.03.013","article-title":"Pathogenesis of hyperostosis: a key role for mesenchymatous cells?","volume":"80","author":"Berthelot","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.humimm.2015.09.038_b0275","doi-asserted-by":"crossref","first-page":"A53","DOI":"10.1136\/ard.2010.129643k","article-title":"Rheumatoid adipose tissue is a potent source of cytokines","volume":"69","author":"Jastrzebska","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.humimm.2015.09.038_b0280","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00296-010-1651-7","article-title":"The serum levels of resistin in ankylosing spondylitis patients: a pilot study","volume":"32","author":"Kocabas","year":"2012","journal-title":"Rheumatol. Int."},{"issue":"4","key":"10.1016\/j.humimm.2015.09.038_b0285","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.bbrc.2005.06.202","article-title":"Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway","volume":"334","author":"Silswal","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.humimm.2015.09.038_b0290","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/art.38968","article-title":"Serum adipokine levels in patients with ankylosing spondylitis and their relationship to clinical parameters and radiographic spinal progression","volume":"67","author":"Syrbe","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.humimm.2015.09.038_b0295","doi-asserted-by":"crossref","first-page":"860651","DOI":"10.1155\/2014\/860651","article-title":"Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis","volume":"2014","author":"Genre","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"5","key":"10.1016\/j.humimm.2015.09.038_b0300","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.berh.2006.06.009","article-title":"Contemporary concepts of inflammation, damage and repair in rheumatic diseases","volume":"20","author":"Luyten","year":"2006","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.humimm.2015.09.038_b0305","doi-asserted-by":"crossref","first-page":"203705","DOI":"10.1155\/2013\/203705","article-title":"Th17 and Treg Cells in Bone Related Diseases","volume":"2013","author":"Wang","year":"2013","journal-title":"Clin. Dev. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2015.09.038_b0310","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"TH-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2015.09.038_b0315","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","article-title":"The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease","volume":"148","author":"Afzali","year":"2007","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2015.09.038_b0320","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/scrt216","article-title":"Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells","volume":"4","author":"Luz-Crawford","year":"2013","journal-title":"Stem Cell Res. Ther."},{"issue":"7350","key":"10.1016\/j.humimm.2015.09.038_b0325","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature10160","article-title":"In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche","volume":"474","author":"Fujisaki","year":"2011","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.humimm.2015.09.038_b0330","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/sj.bmt.1703686","article-title":"Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases","volume":"30","author":"Hinterberger","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.humimm.2015.09.038_b0335","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/bmj.300.6729.908","article-title":"Clearance of severe psoriasis after allogeneic bone marrow transplantation","volume":"300","author":"Eedy","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.humimm.2015.09.038_b0340","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ajh.10169","article-title":"Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature","volume":"71","author":"Kanamori","year":"2002","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.humimm.2015.09.038_b0345","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bmt.1704558","article-title":"Adoptive immunotherapy after bone marrow transplantation in a patient with relapsed acute myeloid leukaemia and severe psoriasis","volume":"34","author":"Windrum","year":"2004","journal-title":"Bone Marrow Transplant."},{"issue":"7","key":"10.1016\/j.humimm.2015.09.038_b0350","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0301-472X(00)00172-7","article-title":"Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukaemia and severe systemic psoriasis and psoriatic polyarthritis","volume":"28","author":"Slavin","year":"2000","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.humimm.2015.09.038_b0355","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/ard.2005.039479","article-title":"Amelioration of severe psoriasis with psoriatic arthritis for 20 years after allogeneic haematopoietic stem cell transplantation","volume":"65","author":"Woods","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"27","key":"10.1016\/j.humimm.2015.09.038_b0360","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1200\/JCO.2008.17.6560","article-title":"Complete remission of psoriasis after autologous hematopoietic stem-cell transplantation for multiple myeloma","volume":"26","author":"Braiteh","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.humimm.2015.09.038_b0365","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/rheumatology\/39.5.563","article-title":"Autologous stem cell transplantation in a lymphoma patient with a long history of ankylosing spondylitis","volume":"39","author":"Jantumen","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.humimm.2015.09.038_b0370","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/bmt.2012.44","article-title":"First autologous hematopoietic SCT for ankylosing spondylitis: a case report and clues to understanding the therapy","volume":"47","author":"Britanova","year":"2012","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.humimm.2015.09.038_b0375","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1752-1947-6-250","article-title":"Regression of syndesmophyte after bone marrow transplantation for acute myeloid leukemia in a patient with ankylosing spondylitis: a case report","volume":"6","author":"Yang","year":"2012","journal-title":"J. Med. Case Rep."},{"issue":"2","key":"10.1016\/j.humimm.2015.09.038_b0380","first-page":"455","article-title":"Inhibitory effect of human umbilical cord-derived mesenchymal stem cells on interleukin-17 production in peripheral blood T cells from spondyloarthritis patients","volume":"21","author":"Huang","year":"2013","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.humimm.2015.09.038_b0385","article-title":"Effects and safety of allogenic mesenchymal stem cells intravenous infusion in active ankylosing spondylitis patients who failed NSAIDs: a 20 week clinical trial","author":"Wang","year":"2013","journal-title":"Cell Transplant."},{"key":"10.1016\/j.humimm.2015.09.038_b0390","unstructured":"ClinicalTrials.gov, Safety and efficacy study of umbilical cord\/placenta-derived mesenchymal stem cells to treat ankylosing spondylitis, ClinicalTrials.gov identifier: NCT01420432, Retrieved from <www.clinicaltrials.gov> on 26th May 2014."},{"key":"10.1016\/j.humimm.2015.09.038_b0395","unstructured":"ClinicalTrials.gov, A molecule basic study of early warning of new pathogenic risk of ankylosing spondylitis, ClinicalTrial.gov identifier: NCT01709656, Retrieved from <www.clinicaltrials.gov> on 26th May 2014."},{"key":"10.1016\/j.humimm.2015.09.038_b0400","unstructured":"Chinese Clinical Trial Registry, Clinical study of mecenchymal stem cells transplantation in ankylosing spondylitis, Registration number: ChiCTR-TRC-11001417 Retrieved from <http:\/\/www.chictr.org\/en\/proj\/show.aspx?proj=1572> on 26th May 2014."},{"issue":"4 Pt 2","key":"10.1016\/j.humimm.2015.09.038_b0405","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/pr.2011.57","article-title":"Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseases","volume":"71","author":"Daikeler","year":"2012","journal-title":"Pediatr. Res."},{"issue":"1","key":"10.1016\/j.humimm.2015.09.038_b0410","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.semarthrit.2008.03.010","article-title":"The development of inflammatory arthritis and other rheumatic diseases following stem cell transplantation","volume":"39","author":"Barnabe","year":"2009","journal-title":"Semin. Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.humimm.2015.09.038_b0415","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2141.2012.09070.x","article-title":"Management of autoimmune diseases after haematopoietic stem cell transplantation","volume":"157","author":"Holbro","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.humimm.2015.09.038_b0420","doi-asserted-by":"crossref","first-page":"581657","DOI":"10.1155\/2014\/581657","article-title":"Autoimmune complications after haematopoietic stem cell transplantation in children with nonmalignant disorders","volume":"2014","author":"Khalil","year":"2014","journal-title":"Sci. World J."},{"issue":"2","key":"10.1016\/j.humimm.2015.09.038_b0425","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12015-011-9312-0","article-title":"Immunosuppressive properties of mesenchymal stem cells","volume":"8","author":"Abumaree","year":"2012","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.humimm.2015.09.038_b0430","doi-asserted-by":"crossref","first-page":"459510","DOI":"10.1155\/2011\/459510","article-title":"Mesenchymal stem cells: angels or demons?","volume":"2011","author":"Wong","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.humimm.2015.09.038_b0435","article-title":"Role of mesenchymal stem cells in leukaemia: Dr. Jekyll or Mr. Hyde?","author":"Wong","year":"2013","journal-title":"Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.humimm.2015.09.038_b0440","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2133.1997.tb03715.x","article-title":"Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity","volume":"137","author":"Snowden","year":"1997","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.humimm.2015.09.038_b0445","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/rheumatology\/38.1.89","article-title":"Transmission of psoriatic arthritis by allogeneic bone marrow transplantation for chronic myelogenous leukemia from an HLA-identical donor","volume":"38","author":"Daikeler","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.humimm.2015.09.038_b0450","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/sj.bmt.1702565","article-title":"First manifestations of seronegative spondyloarthropathy following autologous stem cell transplantation in JLB-B27 positive patients","volume":"26","author":"Koch","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.humimm.2015.09.038_b0455","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2474-11-132","article-title":"Undifferentiated spondyloarthritis following allogeneic stem cell transplantation","volume":"11","author":"Karia","year":"2010","journal-title":"BMC Musculoskelet. Disord."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885915004759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885915004759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T20:56:09Z","timestamp":1537304169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885915004759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":91,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0198885915004759"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2015.09.038","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of stem cells in spondyloarthritis: Pathogenesis, treatment and complications","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2015.09.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}